IVF treatment needs a more holistic and individualised approach, a world leader in fertility and reproductive health will say today at the Fertility 2017 conference in Edinburgh.

 

Fertility 2017 is the 10th joint conference of the UK Fertility Societies: the Association of Clinical Embryologists, the British Fertility Society and the Society for Reproduction & Fertility.

 

Professor Bart Fauser, Professor of Reproductive Medicine, from the University of Utrecht, The Netherlands and Fellow ad eundem of the Royal College of Obstetricians and Gynaecologists (RCOG) will give an overview of ovarian stimulation for infertility treatment over the years and looking to the future.

 

He will say that there are several forms of ovarian stimulation, mainly treatment of infertility due to abnormal ovarian function. IVF success rates have improved over the years with improvements in laboratory performance and techniques used, however, Professor Fauser questions the complex and costly ovarian stimulation regimens requiring many hospital visits and the effects on patients.

 

Professor Fauser will say: “We need to look at IVF more from a holistic perspective. At the end of the day, the outcome most relevant for the couple, is what are the chances for a healthy child per treatment, which may include multiple cycles. And what is the burden of treatment and cost for the families and society.”

 

He will also talk about mild ovarian stimulation for IVF and multiple studies confirm its effectiveness, in the context of reduced drug cost and burden of treatment.

 

Moreover he will discuss how individual variability can be observed in ovarian response to stimulation and in recent years biomarkers have been developed predicting this. “This concept should be developed further, but initial observations suggest that such markers can be used to individualise dosing of ovarian stimulation, representing an important step towards improved, patient tailored care in IVF,” he will say.

 

Professor Adam Balen, Chair of the British Fertility Society, adds:

 

“Professor Bart Fauser has had a profound influence on modern clinical practice, training and inspiring a generation of researchers and new leaders in the field of reproductive medicine. It is our duty to individualise our management to specifically suit a patient’s needs and use the lowest effective dose to stimulate the ovaries during fertility treatments.”

 

Ends

 

Fertility 2017 runs from the 5-7 January and is one of the largest UK events focussing on fertility and reproductive medicine. More information and the programme can be found here: http://fertilityconference.org/

 

For British Fertility Society media enquiries please contact the RCOG press office on 020 7772 6375 or email pressoffice@rcog.org.uk